Structure of angiotensin I-converting enzyme

被引:82
作者
Sturrock, ED
Natesh, R
van Rooyen, JM
Acharya, KR
机构
[1] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England
[2] Univ Cape Town, Fac Hlth Sci, Div Med Biochem, ZA-7925 Cape Town, South Africa
关键词
metallopeptidase; angiotensin I-converting enzyme; Drosophila angiotensin converting enzyme homologue; neurolysin; Pyrococcus furiosus carboxypeptidase; structure-based drug design;
D O I
10.1007/s00018-004-4239-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiotensin-converting enzyme (ACE) is a zinc- and chloride-dependent metallopeptidase that plays a vital role in the metabolism of biologically active peptides. Until recently, much of the inhibitor design and mechanism of action of this ubiquitous enzyme was based on the structures of carboxypeptidase A and thermolysin. When compared to the recently solved structures of the testis isoform of ACE (tACE) and its Drosophila homologue (AnCE), carboxypeptidase A showed little structural homology outside of the active site, while thermolysin revealed significant but less marked overall similarity. The ellipsoid-shaped structure of tACE, which has a preponderance of alpha-helices, is characterised by a core channel that has a constriction approximately 10 Angstrom from its opening where the zinc-binding active site is located. Comparison of the native protein with the inhibitor-bound form (lisinopril-tACE) does not reveal any striking differences in the conformation of the inhibitor binding site, disfavouring an open and closed configuration. However, the inhibitor complex does provide insights into the network of hydrogen-bonding and ionic interactions in the active site as well as the mechanism of ACE substrate hydrolysis. The three-dimensional structure of ACE now paves the way for the rational design of a new generation of domain-selective ACE inhibitors.
引用
收藏
页码:2677 / 2686
页数:10
相关论文
共 50 条
[1]   ACE revisited: A new target for structure-based drug design [J].
Acharya, KR ;
Sturrock, ED ;
Riordan, JF ;
Ehlers, MRW .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (11) :891-902
[2]  
[Anonymous], 1990, HYPERTENSION PATHOPH
[3]   Crystal structure of a novel carboxypeptidase from the hyperthermophilic Archaeon Pyrococcus furiosus [J].
Arndt, JW ;
Hao, B ;
Ramakrishnan, V ;
Cheng, T ;
Chan, SI ;
Chan, MK .
STRUCTURE, 2002, 10 (02) :215-224
[4]   ALSCRIPT - A TOOL TO FORMAT MULTIPLE SEQUENCE ALIGNMENTS [J].
BARTON, GJ .
PROTEIN ENGINEERING, 1993, 6 (01) :37-40
[5]   New aspects on angiotensin-converting enzyme: From gene to disease [J].
Baudin, B .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (03) :256-265
[6]   Structure of neurolysin reveals a deep channel that limits substrate access [J].
Brown, CK ;
Madauss, K ;
Lian, W ;
Beck, MR ;
Tolbert, WD ;
Rodgers, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) :3127-3132
[7]   ACTIVATION OF ANGIOTENSIN CONVERTING ENZYME BY MONO-VALENT ANIONS [J].
BUNNING, P ;
RIORDAN, JF .
BIOCHEMISTRY, 1983, 22 (01) :110-116
[8]   Defining the boundaries of the testis angiotensin I-converting enzyme ectodomain [J].
Chubb, AJ ;
Schwager, SLU ;
Woodman, ZL ;
Ehlers, MRW ;
Sturrock, ED .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 297 (05) :1225-1230
[9]  
CORVOL P, 1998, HDB PROTEOLYTIC ENZY, P1066
[10]   ANGIOTENSIN-CONVERTING ENZYME - NEW CONCEPTS CONCERNING ITS BIOLOGICAL ROLE [J].
EHLERS, MRW ;
RIORDAN, JF .
BIOCHEMISTRY, 1989, 28 (13) :5311-5318